Lipoxin A4 modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism

European Journal of Immunology

Volumn 44, Issue 2, 2014, Pages 357-369

  Ramon, Sesquile ^a   Bancos, Simona ^a   Serhan, Charles N ^b   Phipps, Richard P ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Antibodies; B cells; Human; Lipoxin; Memory responses

Indexed keywords

ALX RECEPTOR; B LYMPHOCYTE ANTIBODY; CD19 ANTIGEN; CD27 ANTIGEN; FPR2 PROTEIN; FPR2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOXIN A; MESSENGER RNA; RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FATTY ACID ANALYSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; IN VIVO STUDY; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ADAPTIVE IMMUNITY; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIBODIES; B-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; INFLAMMATION; LIPOXINS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PROTEIN TRANSPORT; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84893534401     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201343316     Document Type: Article

References (57)

1. Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N. and Gronert, K., Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 2000. 192: 1197-1204.
2. Serhan, C. N., Chiang, N. and Van Dyke, T. E., Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008. 8: 349-361.
3. Serhan, C. N. and Petasis, N. A., Resolvins and protectins in inflammation resolution. Chem. Rev. 2011. 111: 5922-5943.
4. Harris, S. G., Padilla, J., Koumas, L., Ray, D. and Phipps, R. P., Prostaglandins as modulators of immunity. Trends Immunol. 2002. 23: 144-150.
5. Haeggstrom, J. Z. and Funk, C. D., Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem. Rev. 2011. 111: 5866-5898.
6. Serhan, C. N., Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostagl. Leukot. Essent. Fatty Acids 2005. 73: 141-162.
7. Parkinson, J. F., Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation. Inflamm. Allergy Drug Targets 2006. 5: 91-106.
8. Levy, B. D., Romano, M., Chapman, H. A., Reilly, J. J., Drazen, J. and Serhan, C. N., Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5, 8, 11-cis-13-trans-eicosatetraenoic acid and lipoxins. J. Clin. Invest. 1993. 92: 1572-1579.
9. Serhan, C. N. and Sheppard, K. A., Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro. J. Clin. Invest. 1990. 85: 772-780.
10. Serhan, C. N., Krishnamoorthy, S., Recchiuti, A. and Chiang, N., Novel anti-inflammatory-pro-resolving mediators and their receptors. Curr. Top Med. Chem. 2011. 11: 629-647.
11. Fiore, S., Maddox, J. F., Perez, H. D. and Serhan, C. N., Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J. Exp. Med. 1994. 180: 253-260.
12. Dufton, N., Hannon, R., Brancaleone, V., Dalli, J., Patel, H. B., Gray, M., D'Acquisto, F. et al., Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation. J. Immunol. 2010. 184: 2611-2619.
13. Ramon, S., Gao, F., Serhan, C. N. and Phipps, R. P., Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells. J. Immunol. 2012. 189: 1036-1042.
14. Poulsen, R. C., Gotlinger, K. H., Serhan, C. N. and Kruger, M. C., Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake. Am. J. Hematol. 2008. 83: 437-445.
15. Schneider, C., Keeney, D. S., Boeglin, W. E. and Brash, A. R., Detection and cellular localization of 12R-lipoxygenase in human tonsils. Arch. Biochem. Biophys. 2001. 386: 268-274.
16. Ariel, A., Chiang, N., Arita, M., Petasis, N. A. and Serhan, C. N., Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. J. Immunol. 2003. 170: 6266-6272.
17. Godson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N. and Brady, H. R., Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 2000. 164: 1663-1667.
18. Lee, T. H., Horton, C. E., Kyan-Aung, U., Haskard, D., Crea, A. E. and Spur, B. W., Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Clin. Sci. 1989. 77: 195-203.
19. Takano, T., Clish, C. B., Gronert, K., Petasis, N. and Serhan, C. N., Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. J. Clin. Invest. 1998. 101: 819-826.
20. Colgan, S. P., Serhan, C. N., Parkos, C. A., Delp-Archer, C. and Madara, J. L., Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J. Clin. Invest. 1993. 92: 75-82.
21. Devchand, P. R., Arita, M., Hong, S., Bannenberg, G., Moussignac, R. L., Gronert, K. and Serhan, C. N., Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. Faseb J. 2003. 17: 652-659.
22. Arita, M., Yoshida, M., Hong, S., Tjonahen, E., Glickman, J. N., Petasis, N. A., Blumberg, R. S. et al., Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. USA 2005. 102: 7671-7676.
23. Hasturk, H., Kantarci, A., Ohira, T., Arita, M., Ebrahimi, N., Chiang, N., Petasis, N. A. et al., RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis. Faseb J. 2006. 20: 401-403.
24. Levy, B. D., De Sanctis, G. T., Devchand, P. R., Kim, E., Ackerman, K., Schmidt, B. A., Szczeklik, W. et al., Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat. Med. 2002. 8: 1018-1023.
25. Bonnans, C., Chanez, P. and Chavis, C., Lipoxins in asthma: potential therapeutic mediators on bronchial inflammation? Allergy 2004. 59: 1027-1041.
26. Migeotte, I., Communi, D. and Parmentier, M., Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev. 2006. 17: 501-519.
27. Maddox, J. F., Hachicha, M., Takano, T., Petasis, N. A., Fokin, V. V. and Serhan, C. N., Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J. Biol. Chem. 1997. 272: 6972-6978.
28. Simiele, F., Recchiuti, A., Mattoscio, D., De Luca, A., Cianci, E., Franchi, S., Gatta, V. et al., Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity. Faseb J. 2012. 26: 1323-1333.
29. Waechter, V., Schmid, M., Herova, M., Weber, A., Gunther, V., Marti-Jaun, J., Wust, S. et al., Characterization of the promoter and the transcriptional regulation of the lipoxin A4 receptor (FPR2/ALX) gene in human monocytes and macrophages. J. Immunol. 2012. 188: 1856-1867.
30. Fiore, S., Romano, M., Reardon, E. M. and Serhan, C. N., Induction of functional lipoxin A4 receptors in HL-60 cells. Blood 1993. 81: 3395-3403.
31. Ye, R. D., Boulay, F., Wang, J. M., Dahlgren, C., Gerard, C., Parmentier, M., Serhan, C. N. et al., International union of basic and clinical pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol. Rev. 2009. 61: 119-161.
32. Sodin-Semrl, S., Taddeo, B., Tseng, D., Varga, J. and Fiore, S., Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J. Immunol. 2000. 164: 2660-2666.
33. Serhan, C. N., Maddox, J. F., Petasis, N. A., Akritopoulou-Zanze, I., Papayianni, A., Brady, H. R., Colgan, S. P. et al., Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 1995. 34: 14609-14615.
34. Aliberti, J., Hieny, S., Reis e Sousa, C., Serhan, C. N. and Sher, A., Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat. Immunol. 2002. 3: 76-82.
35. Aliberti, J., Serhan, C. and Sher, A., Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J. Exp. Med. 2002. 196: 1253-1262.
36. Krishnamoorthy, S., Recchiuti, A., Chiang, N., Yacoubian, S., Lee, C. H., Yang, R., Petasis, N. A. et al., Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc. Natl. Acad. Sci. USA 2010. 107: 1660-1665.
37. Machado, F. S., Johndrow, J. E., Esper, L., Dias, A., Bafica, A., Serhan, C. N. and Aliberti, J., Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent. Nat. Med. 2006. 12: 330-334.
38. Stenfeldt, A. L., Karlsson, J., Wenneras, C., Bylund, J., Fu, H. and Dahlgren, C., Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. Inflammation 2007. 30: 224-229.
39. Jozsef, L., Zouki, C., Petasis, N. A., Serhan, C. N. and Filep, J. G., Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc. Natl. Acad. Sci. USA 2002. 99: 13266-13271.
40. Wang, B., Gong, X., Wan, J. Y., Zhang, L., Zhang, Z., Li, H. Z. and Min, S., Resolvin D1 protects mice from LPS-induced acute lung injury. Pulm. Pharmacol. Ther. 2011. 24: 434-441.
41. Thomas, M. D., Srivastava, B. and Allman, D., Regulation of peripheral B cell maturation. Cell Immunol. 2006. 239: 92-102.
42. Paganelli, R., Quinti, I., Fagiolo, U., Cossarizza, A., Ortolani, C., Guerra, E., Sansoni, P. et al., Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population. Clin. Exp. Immunol. 1992. 90: 351-354.
43. Bancos, S. and Phipps, R. P., Memory B cells from older people express normal levels of cyclooxygenase-2 and produce higher levels of IL-6 and IL-10 upon in vitro activation. Cell Immunol. 2010. 266: 90-97.
44. Lanzavecchia, A. and Sallusto, F., Human B cell memory. Curr. Opin. Immunol. 2009. 21: 298-304.
45. Schmidlin, H., Diehl, S. A. and Blom, B., New insights into the regulation of human B-cell differentiation. Trends Immunol. 2009. 30: 277-285.
46. Zhang, L., Zhang, X., Wu, P., Li, H., Jin, S., Zhou, X., Li, Y. et al., BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis. Inflamm. Res. 2008. 57: 157-162.
47. Dona, M., Fredman, G., Schwab, J. M., Chiang, N., Arita, M., Goodarzi, A., Cheng, G. et al., Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood 2008. 112: 848-855.
48. Bafica, A., Scanga, C. A., Serhan, C., Machado, F., White, S., Sher, A. and Aliberti, J., Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production. J. Clin. Invest. 2005. 115: 1601-1606.
49. Hong, S., Porter, T. F., Lu, Y., Oh, S. F., Pillai, P. S. and Serhan, C. N., Resolvin E1 metabolome in local inactivation during inflammation-resolution. J. Immunol. 2008. 180: 3512-3519.
50. Steinhilber, D., Radmark, O. and Samuelsson, B., Transforming growth factor beta upregulates 5-lipoxygenase activity during myeloid cell maturation. Proc. Natl. Acad. Sci. USA 1993. 90: 5984-5988.
51. Dalli, J., Winkler, J. W., Colas, R. A., Arnardottir, H., Cheng, C. Y., Chiang, N., Petasis, N. A. et al., Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents. Chem. Biol. 2013. 20: 188-201.
52. Chen, M., Divangahi, M., Gan, H., Shin, D. S., Hong, S., Lee, D. M., Serhan, C. N. et al., Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J. Exp. Med. 2008. 205: 2791-2801.
53. Bernard, M. P. and Phipps, R. P., CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production. Clin. Immunol. 2007. 125: 138-148.
54. Ryan, E. P., Pollock, S. J., Murant, T. I., Bernstein, S. H., Felgar, R. E. and Phipps, R. P., Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody production. J. Immunol. 2005. 174: 2619-2626.
55. Breitman, T. R., Selonick, S. E. and Collins, S. J., Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA 1980. 77: 2936-2940.
56. Garcia-Bates, T. M., Bernstein, S. H. and Phipps, R. P., Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells. Clin. Cancer Res. 2008. 14: 6414-6425.
57. Alisi, A., Giannini, C., Spaziani, A., Caini, P., Zignego, A. L. and Balsano, C., Involvement of PI3K in HCV-related lymphoproliferative disorders. J. Cell Physiol. 2008. 214: 396-404.